- Approval Id
- c5bb7a0f0a141717
- Drug Name
- DEVODIL 200 TABLET 200 mg
- Product Name
- DEVODIL 200 TABLET 200 mg
- Approval Number
- SIN09937P
- Approval Date
- 1998-08-07
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- **Dosage**
In the treatment of schizophrenia initial doses of 200 to 400mg twice daily by mouth may be given, increased if necessary up to a maximum of 1,2g twice daily. Usual maintenance doses are 400 to 800mg daily by mouth. The usual dose of Devodil in the treatment of nausea, vomiting is 150 to 300mg daily in divided doses.
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
Devodil is indicated for the treatment of psychosomatic components of organic diseases, e.g., nausea, vomiting; and acute or chronic psychiatric disorders.
- Contraindications
- **Contra-indications**
Devodil is contra-indicated in patients with pheochromocytoma and during pregnancy.
- Atc Code
- N05AL01
- Atc Item Name
- sulpiride
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
- Company Detail Path
- /organization/goldplus-universal-pte-ltd
